Sepsis & infection

Endothelial dysfunction in critically ill patients with sepsis and COVID-19 using the albumin transudation rate: A pilot study

J Crit CarePublished Prospective observational pilot study

Authors' conclusion

ATR was persistently elevated in critically ill patients with sepsis and COVID-19. Sepsis exhibited significantly higher ATR values, suggesting a more pronounced endothelial dysfunction.

Study context

Population
Critically ill ICU patients with sepsis or COVID-19, 2022
Participants
36 patients · 3 ICUs
Exposure
Sepsis vs COVID-19
  • Sepsisn = 18
  • COVID-19n = 18reference
Outcome
Albumin transudation rate (ATR), measured with a 131I-albumin tracer
Follow-up
Days 1, 2, 3, 7, and 10
Methodological detailsmulticentre (3 ICUs)
  • Multicentre (3 ICUs)

Main finding

As reported in the abstract

ATR · throughout the ICU stay
  • Albumin transudation rate (ATR) significantly higher in sepsis vs COVID-19 throughout the ICU stay, despite lower admission severity scores in sepsis

Observational data: associations, not effects.

Further findings

Clinical assessment of volume status vs measured total blood volume (TBV)

Clinical assessment frequently misclassified TBV; patients often deemed hypervolemic when objectively hypovolemic, in both conditions

Original publication

Endothelial dysfunction in critically ill patients with sepsis and COVID-19 using the albumin transudation rate: A pilot study. J Crit Care. Published 23 August 2025. doi:10.1016/j.jcrc.2025.155237

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.